BMS-480404

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBMS-480404
Drug Alias NameBMS-480404
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid binding protein 5 inhibitors
TargetsFatty acid binding protein 5
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A